The Androgen Receptor Sensitivity Index is a clinical metric or theoretical construct that quantifies the responsiveness of target tissues to circulating androgen hormones, such as testosterone and dihydrotestosterone (DHT). This index reflects the functional capacity of the androgen receptor (AR) rather than merely the hormone concentration itself. A higher index indicates a more efficient cellular response to a given level of androgen signaling.
Origin
This concept originates from the field of molecular endocrinology, where the function and regulation of nuclear hormone receptors are studied in detail. It extends beyond simple hormone measurement by incorporating the genetic and epigenetic factors that govern receptor expression, binding affinity, and subsequent signal transduction. The clinical utility of the index stems from its ability to explain symptoms of androgen deficiency even when serum levels appear adequate.
Mechanism
The sensitivity is governed by factors including AR gene polymorphisms, co-regulator protein availability, and post-translational modifications of the receptor. Enhanced sensitivity facilitates the binding of androgens to the AR, leading to its translocation into the nucleus and subsequent modulation of gene transcription. Optimizing this index allows for better utilization of endogenous or administered hormones, promoting anabolic effects in muscle, bone, and central nervous system tissues.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.